Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate. II. Effect on the ability of murine macrophages to present antigen

Immunopharmacology. 1985 Dec;10(3):181-9. doi: 10.1016/0162-3109(85)90024-4.

Abstract

Acute administration of 10 mg/kg O,O,S-trimethyl phosphorothioate (OOS-TMP) for 24 h has been shown to suppress the in vitro generation of cytotoxic T lymphocyte responses and antibody-secreting cells to sheep red blood cells and to increase interleukin-2 production. Macrophages were shown to be the splenic cell population most affected by OOS-TMP pretreatment. In this report, the ability of macrophages from OOS-TMP-treated animals to function in antigen presentation was shown to be significantly decreased. In addition, macrophages from treated animals had increased phagocytic capability and interleukin-l production. However, the percentage of Ia-positive macrophages present in splenic populations was decreased following OOS-TMP treatment. A decrease in antigen presenting ability and the number of Ia-positive macrophages may explain the reversible suppression in cytotoxic T lymphocytes and antibody responses reported previously.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigen-Presenting Cells / drug effects
  • Female
  • Immune Tolerance / drug effects*
  • Macrophages / immunology*
  • Major Histocompatibility Complex / drug effects
  • Mice
  • Mice, Inbred Strains
  • Organothiophosphates / toxicity*
  • Organothiophosphorus Compounds / toxicity*
  • Spleen / cytology

Substances

  • Organothiophosphates
  • Organothiophosphorus Compounds
  • O,O,S-trimethyl phosphorothioate